TONGHUA DONGBAO

Dongbao Enterprise Group Co. Ltd. is a leading biopharmaceutical company actively engaged in R&D, production and marketing of high-quality biological products. As one of the well-known manufacturer of RH insulin, in the segment of diabetes mellitus, we have also developed glargine, aspart, lispro and degludec, as well as liraglutide and delaglutide. In Dongbao’s biotech portfolio, different monoclonal antibodies (adalimumab, etanercept and rituximab), recombinant human albumin and recombinant coagulation factor VII & VIII are also well developed.